Stock overview
Merck & Co. Inc.
Explore the company, reported ownership, price history, and available source evidence.
Merck develops medicines and vaccines, with major businesses in oncology, infectious disease, and animal health.
- Last close
- $148.78
- · MRK
- Tracked holders
- 5 funds
- Latest available 13F per fund
MRK · USD
Price
$148.78
+$75.42
(+102.81%)
over selected range
Close · Sep 25, 2026
Market open
1255 stored daily closes
$148.78
Sep 25, 2026
- Range low
- $72.28
- Range high
- $156.45
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Samlyn Capital largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | −22% 26'Q2 | $72,699,519 | 1.18% |
| Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +4% 26'Q2 | $67,968,405 | 0.16% |
| Fairfax Financial Holdings position history Q2 2026 · filed Aug 14, 2026 · SEC filing | — | $22,198,631 | 0.84% |
| Central Securities position history Q2 2026 · filed Aug 10, 2026 · SEC filing | — | $19,275,000 | 1.44% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+4% 26'Q2 | $5,505,496 | 0.13% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market